Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Cash from Investing Activities (2019 - 2023)

Historic Cash from Investing Activities for ADC Therapeutics (ADCT) over the last 5 years, with Q4 2023 value amounting to -$327000.0.

  • ADC Therapeutics' Cash from Investing Activities rose 5223.55% to -$327000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was -$3.2 million, marking a year-over-year decrease of 36812.23%. This contributed to the annual value of -$867000.0 for FY2024, which is 7304.1% up from last year.
  • Per ADC Therapeutics' latest filing, its Cash from Investing Activities stood at -$327000.0 for Q4 2023, which was up 5223.55% from -$661000.0 recorded in Q3 2023.
  • In the past 5 years, ADC Therapeutics' Cash from Investing Activities ranged from a high of -$47.0 in Q3 2019 and a low of -$1.2 million during Q2 2023
  • For the 5-year period, ADC Therapeutics' Cash from Investing Activities averaged around -$293734.3, with its median value being -$2338.0 (2021).
  • In the last 5 years, ADC Therapeutics' Cash from Investing Activities skyrocketed by 9986.75% in 2021 and then crashed by 26013622.05% in 2023.
  • Quarter analysis of 5 years shows ADC Therapeutics' Cash from Investing Activities stood at -$294.0 in 2019, then crashed by 168607.48% to -$496000.0 in 2020, then soared by 99.83% to -$830.0 in 2021, then crashed by 82383.01% to -$684609.0 in 2022, then skyrocketed by 52.24% to -$327000.0 in 2023.
  • Its Cash from Investing Activities stands at -$327000.0 for Q4 2023, versus -$661000.0 for Q3 2023 and -$1.2 million for Q2 2023.